Coronavirus IRNA compositions and methods of use thereof
US12391945B2 · kind B2 · utility
0Cited by
3References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 2021 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Oct 6, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the coronavirus genome. The invention also relates to methods of using such RNAi agents to inhibit expression of a coronavirus genome and to methods of treating or preventing a coronavirus-associated disease in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.